ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,428.675
0.27%
Brent Oil
84.125
-0.25%
Bitcoin
64,694.22
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:POLB
DateTimeSourceHeadlineSymbolCompany
14/04/202221:36Alliance NewsAlliance NewsTRADING UPDATES: Polar Capital assets up; Brooks Macdonald funds fallLSE:POLBPoolbeg Pharma Plc
14/04/202221:36Alliance NewsAlliance NewsTRADING UPDATES: Polar Capital assets up; Brooks Macdonald funds fallLSE:POLBPoolbeg Pharma Plc
14/04/202207:00UK RegulatoryPoolbeg Pharma PLC Key POLB 002 European Patent GrantedLSE:POLBPoolbeg Pharma Plc
11/04/202221:58Alliance NewsAlliance NewsTRADING UPDATES: TruFin raises GBP10 million, Afentra preferred bidderLSE:POLBPoolbeg Pharma Plc
11/04/202221:58Alliance NewsAlliance NewsTRADING UPDATES: TruFin raises GBP10 million, Afentra preferred bidderLSE:POLBPoolbeg Pharma Plc
11/04/202207:01UK RegulatoryPoolbeg Pharma PLC Distribution in Specie ShareholdersLSE:POLBPoolbeg Pharma Plc
04/04/202212:26UK RegulatoryPoolbeg Pharma PLC Result of AGMLSE:POLBPoolbeg Pharma Plc
31/03/202222:07Alliance NewsAlliance NewsTRADING UPDATES: SSE's Transmission raises cash; Croda gets UK grantLSE:POLBPoolbeg Pharma Plc
31/03/202222:07Alliance NewsAlliance NewsTRADING UPDATES: SSE's Transmission raises cash; Croda gets UK grantLSE:POLBPoolbeg Pharma Plc
31/03/202207:01UK RegulatoryPoolbeg Pharma PLC POLB001 Update - Clinical Trial Agreement SignedLSE:POLBPoolbeg Pharma Plc
30/03/202220:25Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture MarketLSE:POLBPoolbeg Pharma Plc
30/03/202220:25Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture MarketLSE:POLBPoolbeg Pharma Plc
30/03/202207:00UK RegulatoryPoolbeg Pharma PLC Commencement of trading on US OTCQB marketLSE:POLBPoolbeg Pharma Plc
24/03/202221:01Alliance NewsAlliance NewsTRADING UPDATES: Getech wins mining contracts; Bluejay starts drillingLSE:POLBPoolbeg Pharma Plc
24/03/202221:01Alliance NewsAlliance NewsTRADING UPDATES: Getech wins mining contracts; Bluejay starts drillingLSE:POLBPoolbeg Pharma Plc
24/03/202207:00UK RegulatoryPoolbeg Pharma PLC AI deal signed with CytoReasonLSE:POLBPoolbeg Pharma Plc
09/03/202207:01UK RegulatoryPoolbeg Pharma PLC Notice of AGMLSE:POLBPoolbeg Pharma Plc
03/03/202219:32Alliance NewsAlliance NewsTRADING UPDATES: Avation loss narrows; Franchise Brands profit risesLSE:POLBPoolbeg Pharma Plc
03/03/202219:32Alliance NewsAlliance NewsTRADING UPDATES: Avation loss narrows; Franchise Brands profit risesLSE:POLBPoolbeg Pharma Plc
03/03/202207:00UK RegulatoryPoolbeg Pharma PLC Final ResultsLSE:POLBPoolbeg Pharma Plc
28/02/202207:01UK RegulatoryPoolbeg Pharma PLC Notice of ResultsLSE:POLBPoolbeg Pharma Plc
24/02/202221:57Alliance NewsAlliance NewsTRADING UPDATES: Enwell shuts down operations; i3 ups oil productionLSE:POLBPoolbeg Pharma Plc
24/02/202221:57Alliance NewsAlliance NewsTRADING UPDATES: Enwell shuts down operations; i3 ups oil productionLSE:POLBPoolbeg Pharma Plc
24/02/202207:01UK RegulatoryPoolbeg Pharma PLC Artificial Intelligence deal with OneThree BiotechLSE:POLBPoolbeg Pharma Plc
31/01/202222:06Alliance NewsAlliance NewsTRADING UPDATES: Hiro plans acquisition vehicle IPO; Aquila reviewsLSE:POLBPoolbeg Pharma Plc
31/01/202222:06Alliance NewsAlliance NewsTRADING UPDATES: Hiro plans acquisition vehicle IPO; Aquila reviewsLSE:POLBPoolbeg Pharma Plc
31/01/202206:59UK RegulatoryPoolbeg Pharma PLC Confirmation of vaccine platform licence executionLSE:POLBPoolbeg Pharma Plc
17/01/202217:04Alliance NewsAlliance NewsTRADING UPDATES: CentralNic and Pebble tip 2021 earnings riseLSE:POLBPoolbeg Pharma Plc
17/01/202217:04Alliance NewsAlliance NewsTRADING UPDATES: CentralNic and Pebble tip 2021 earnings riseLSE:POLBPoolbeg Pharma Plc
17/01/202207:00UK RegulatoryPoolbeg Pharma PLC Exclusive license of RNA-based immunotherapy assetLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Your Recent History

LSE
BBB
Bigblu Broadband
LSE
TPL
Tethys
LSE
UKOG
Uk Oil & Gas
LSE
SCE
Surface Transforms
LSE
OCN
Ocean Wilsons (holdings)...
LSE
CHAR
Chariot
LSE
TGL
Transglobe Energy
LSE
CHH
Churchill China
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved